Early-time-point 18F-FDG-PET/CT and other prognostic biomarkers of survival in metastatic melanoma patients receiving immunotherapy
, , , , , et
27 févr. 2025
À propos de cet article
Catégorie d'article: research article
Publié en ligne: 27 févr. 2025
Pages: 43 - 53
Reçu: 12 déc. 2024
Accepté: 04 janv. 2025
DOI: https://doi.org/10.2478/raon-2025-0014
Mots clés
© 2025 Nezka Hribernik et al., published by Sciendo
This work is licensed under the Creative Commons Attribution 4.0 International License.
Hribernik, Nezka
Department of Medical Oncology, Institute of Oncology LjubljanaLjubljana, Slovenia
Faculty of Medicine, University of LjubljanaLjubljana, Slovenia
Strasek, Katja
Faculty of Mathematics and Physics, University of LjubljanaLjubljana, Slovenia
Studen, Andrej
Faculty of Mathematics and Physics, University of LjubljanaLjubljana, Slovenia
Experimental Particle Physics Department, Jozef Stefan InstituteLjubljana, Slovenia
Zevnik, Katarina
Department of Nuclear Medicine, Institute of Oncology LjubljanaLjubljana, Slovenia
Skalic, Katja
Department of Nuclear Medicine, Institute of Oncology LjubljanaLjubljana, Slovenia
Jeraj, Robert
Faculty of Mathematics and Physics, University of LjubljanaLjubljana, Slovenia
University of Wisconsin Carbone Cancer CentreMadison, USA
Department of Medical Physics, University of Wisconsin-MadisonMadison, USA
Experimental Particle Physics Department, Jozef Stefan InstituteLjubljana, Slovenia
Rebersek, Martina
Department of Medical Oncology, Institute of Oncology LjubljanaLjubljana, Slovenia
Faculty of Medicine, University of LjubljanaLjubljana, Slovenia